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Received January 28, 2011; accepted June 20, 2011AbstractGonorrhea (Neisseria gonorrhoeae) is a common sexually transmitted infection in women, with a heavy burden on female and neonatal
health, because sequelae occur, such as female infertility, ectopic pregnancy, neonatal ophthalmitis and infection, and chronic pelvic pain.
Prompt and appropriate antibiotic treatment can cure infection and avoid complications. However, adequate treatment is not easy, because early
and rapid identification of gonorrhea is interfered with by many factors, including the complicated mixed microflora of the vagina and cervix,
non-user-friendly culture systems, and lack of immediate availability of results, even with a combination of subjective complaint and high
clinical suspicion. A PubMed search was conducted using the major headings of “gonorrhoea and diagnostic tool” and “Neisseria gonorrhoeae
and diagnostic tool”, before the end of 2010. Recently available methods for the diagnosis of gonorrhea infection in women were included,
including traditional tools and advanced technology. Traditional tools such as microscopic examination and microbial culture have been used
broadly; unfortunately, they have relatively lower specificity or sensitivity, and most importantly, “see-and-treat” is impossible for these infected
women. Advances in technology, such as antigen detection by immunoassay and nucleic acid amplification tests (NAATs), have achieved major
progress in the diagnosis of gonorrhea, because of their accuracy, convenience and time-saving aspects. However, NAATs are expensive, making
their acceptance impossible in developing countries. Detection of pathogens including N. gonorrheae using microarray chips is viewed as
a possible solution, because it is a relatively rapid, easy, inexpensive and sensitive tool, which makes an “identify-and-treat” or point-of-care
policy possible. A rapid and affordable tool with high sensitivity and specificity for detection of gonorrhea in developing countries is still
not available at the time of writing. To make a point-of-care policy possible, advanced technology for aiding diagnosis of gonorrhea is
encouraged and appreciated.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Lower genital tract infection in women is the most common
disease in gynecological clinics.1 The majority of these infec-
tions are caused by mixed pathogens. Treatment is frequently
neglected or delayed,2 especially for sexually transmittedhinese Medical Association. All rights reserved.
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(pelvic inflammatory diseases).3 STIs are also some of the most
common serious diseases in the emergency department. Even
though intensive treatment is used, some STIs are ultimately
complicated with severe sequelae, resultant socioeconomic
problems, infertility, ectopic pregnancy, preterm labor, and
chronic pelvic pain.4 Therefore, it is important to identify these
highly invasive pathogens accurately and rapidly, since prompt
and appropriate antibiotic treatment can lead to patients
avoiding the majority of these complications.
To make an early diagnosis of STIs, familiarity with the
diseases, a high degree of suspicion and easy-to-use diagnostic
methods are important. Chlamydia infection may be one of the
most well-known examples, because of the development of
artificial reproductive techniques and the well-recognized
adverse effects of chlamydia infection on fertility. The poly-
merase chain reaction makes the diagnosis of chlamydia
infection easier and quicker. By contrast, the diagnosis of
Neisseria gonorrhoeae is often overlooked. The causes include
the lack of a formal and organized curriculum in medical
schools or house officer training,5 the lower incidence in the
general population, nonspecific symptoms or signs of infection,
and rare discomfort of infected women. Of course, lack of
simple, accurate and easy-to-use diagnostic methods further
hinders our attention to this detrimental infection in women.
According to the estimate of the World Health Organiza-
tion,6 62 million cases of gonorrhea occur annually world-
wide, and the sequelae of gonorrhea infection in women, such
as the facilitation of human immunodeficiency virus trans-
mission, ocular infections of the newborn, disseminated
infection and infertility, are severe and profound.7 Nearly
blind use of antibiotics for the N. gonorrhoeae infection has
enabled resistant strains to spread widely and rapidly.8 All of
these factors contribute to the necessity of revisiting N. gon-
orrhoeae infection.
In the general population, the estimated prevalence of
gonorrhea infection is around 0.7% to 7%,9,10 and it increases
to 15e35% in specific high-risk groups,11,12 including sex
workers or groups with different risk factors, such as young
age, black ethnicity, frequent sexual contacts,9 and cases with
some specific symptoms, such as mucopurulent cervical
discharge and lower abdominal pain.10
There are several tools that are used currently to establish
diagnosis of gonorrhea infection.2,7,8,10 This review attempts
to describe and compare these methods, and hopefully help
physicians better understand this common but overlooked
sexually transmitted disease.
2. Syndromic approach
This is a subjective and non-consistent method for the
diagnosis of a specific cervical infection. There should be
various symptoms in a cervical infection caused by different
and multiple pathogens in different persons with various
physical conditions. It is nearly impossible to identify the
pathogen simply from symptoms. Moreover, so many asymp-
tomatic women are not aware of the risk of gonorrhea infection.It is believed that gonorrhea infection is most likely
confirmed if mucopurulent discharge is present during vaginal
speculum examination.6 Other factors include history of being
a sex worker and tenderness induced by bimanual examina-
tion. However, mucopurulent discharge (non-clear, yellowish
discharge from the endocervix), friability (easy bleeding)
when the cervix is touched with a swab, or a positive swab test
(yellow discoloration of the swab when inserted in the endo-
cervix) predict only a 50% chance of gonorrhoeae infection.13
In different populations, such as patients from a family
practice, in a prenatal clinic, or in a setting especially for sex
workers, the sensitivity, specificity and positive predictive
value of various methods differ due to fluctuating incidence.10
The average sensitivity and specificity for an approach by
syndrome are <50%.6
Combined with a scoring system using risk factors,14 such
as age, marital status, dyspareunia, and discolored vaginal
discharge, higher sensitivity (60e80%) and specificity (w60%)
have been sporadically reported in certain groups of patients,
using a syndromic approach.10 Despite the low sensitivity and
specificity, it is still an easy, rapid and economic tool for
diagnosis. The syndromic approach remains the main diag-
nostic choice in most developing countries with limited labo-
ratory facilities.15
3. Gram’s stain
Spreading of smear samples from the cervix on a glass slide
and staining with dyes seems an inexpensive and convenient
screening method for diagnosis of infection and malignancy.
Identification of intracellular Gram-negative diplococci under
the microscope after Gram staining is considered an instant and
standard finding, with specificity around 95%.16,17 However, it
is not recommended by the World Health Organization for
diagnosis of cervical infection,6 because of its low detection
rate of near 30%,18 even when well-trained technicians are
available.6 Some have tried to raise the detection ability of
Gram’s stain by using the criteria of finding 10 poly-
morphonuclear neutrophils per high-power field. However, as
an aid to diagnosis, a result with sensitivity <50% is disap-
pointing.16 This might also indicate the minimal role of Pap
smear in identifying cervical infection.
4. Culture
Microbial culture is still accepted by some investigators as
the gold standard for the diagnosis of gonorrhea infection,19,20
and is used as a standard to be compared with the results of
nucleic acid amplification tests (NAATs)19 or other tools.20With
a high specificity (95%) but a questionable detection rate (50%),
this tool no longer satisfies the needs of modern medicine.
Optional conditions such as a CO2-enriched (5e7%) and
body-temperature (37 C) environment, and an enriched
medium such as modified ThayereMartin medium or chocol-
atized medium will achieve a better culture rate.21 These
complicated conditions might explain the questionable sensi-
tivity of this tool. To increase the detection rate, the high
Fig. 1. The structure of the liposomal nanovesicles. SRB¼ sulfo-rhodamine B;
LRB¼ lissamine-rhodamine B.
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culture medium and conditions, and a significant improvement
in culture rate could also be achieved by urgent transportation to
and processing of the specimens in the laboratory.22
Compared to the advanced NAATs, the culturemethod seems
not sensitive enough to be the gold standard of diagnosis of
gonorrheal infection. However, sometimes, the culture method
might provide more accurate information when a NAAT is tar-
geted on a changing gene.23 Moreover, this is still the only
method that provides information about antimicrobial agent
susceptibility. Although resistant strains become increasingly
prevalent, high-quality culture methods will need to be main-
tained to ensure a representative sample for susceptibility
testing.24 Moreover, the culture method can be used as a rescue
approach when symptoms persist even after optimal treatment.
5. Immunoassay
Different immunoassay kits are used as a rapid method to
confirm the genus in the Neisseria family. The products
available on the market include GonoGen, GonoGen II, the
Syva Micro Trak Direct Fluorescent-Antibody test, the Pha-
debact Monoclonal GC OMNI test, and the Gonobio-Test.25
These tools are useful in telling us if the culture is N. gon-
orrhoeae or not. Some use this tool to detect possible infection
from original cervical swabs directly. The sensitivity rates of
currently available rapid tests are between 50% and 70%. The
change of target antigen after routine use may decrease
sensitivity after extinguishing the related subtypes, but
improve the specificity up to 90e100%.11,17
In spite of their lower sensitivity, immunoassays, as rapid
point-of-care tests, might outperform other standard tests in
populations with high sexual activity, such as sexual workers
and/or in those with low return rates in developing countries.26
If treatment can be started at the initial visit, the possibility of
onward transmission of N. gonorrhoeae can be minimized7,18
Immunoassays are an easy-to-use method with rapid diagnosis,
low cost and no requestedmicroscopy, therefore, they seemmore
acceptable than other tools in developing countries.11,17,18,20
6. NAATs
To date, NAATs have provided high specificity of
95e100%, and the best sensitivity of all diagnostic methods,
at around 95%.19,20,22 There are also consistent data among
different NAATs, such as the strand displacement assay (BD
ProbeTec C trachomatis/N gonorrhoeae Amplified DNA
Assay) APTIMA Combo 2 and APTIMA GC assays,19 Ligase
Chain Reaction (Abbott Laboratories, Abbott Park, IL,
USA),20 and Cobas Amplicor (Roche).20 With their extremely
high sensitivity and specificity, they are considered the gold
standard for diagnosis27 and good for different samples, such
as cervical swabs from intrusive speculum examination or
urine from the noninvasive route.28
However, there are still some pitfalls in using these tools.
They can cross-react with other Neisseria species and can be
affected by specimen transport conditions. False-negativereports, compared with culture data, indicate the variation in
the target sequence. Therefore, confirmation with another
NAAT method, which may double the cost, has been recom-
mended.23 In addition, the widespread use of NAATs might
result in decreased isolation of N. gonorrhoeae and ignorance
of possible resistant organisms.
Due to their high cost, NAATs are not recommended as the
only tool for screening. The use of a molecular testing strategy
may be cost-effective when it is supplemented with micros-
copy and culture, to provide prompt treatment and further
microbial susceptibility testing.29 In fact, NAATs are not only
expensive and complicated, but also dependent on highly
trained staff and delicate equipment. These factors all hinder
the widespread use of these techniques in developing coun-
tries.11 Therefore, they might not be suitable as a diagnostic
method in a point-of-care setting.11,18
7. Prospecting method
Advances in high throughput assays such as protein
microarray chip fabrication30 have made it possible to perform
multiple immunoassays with one minimal vaginal sample. Up
to several thousand proteins can be printed and evaluated on
one slide simultaneously.31 In addition, liposomal nano-
vesicles might be used to build up a signal amplifying system
and increase the sensitivity rate of immunoassays.32,33 This
strategy has been used successfully for the detection of an
infectious Escherichia coli strain, with a detection limit
100 CFU/mL,32 and similar immunoassay techniques have
been applied to detect several food-borne pathogens simulta-
neously, including E. coli O157:H7, Salmonella enterica
serovar typhimurium, and Listeria monocytogenes, with
detection limits between 100 and 15,000 CFU/mL.33
The liposomal nanovesicles are composed of outer-surface
bilayer and inner vesicles; there are several hundred thousand
fluorescent dyes contained within the vesicle (Fig. 1), which
amplify the fluorescent signals. These are excellent and easy-
to-use signal carriers in biosense analysis.34 In addition,
antibody microarray is an excellent tool for multiplex detec-
tion of analytes (Fig. 2). The illustrated procedures comprise
several steps. Capture antibodies are first printed on the slide.
After interaction with pathogens, detection antibodies
Fig. 2. The basic principle of detecting microorganisms by microarray chip. SRB¼ sulfo-rhodamine B; LRB¼ lissamine-rhodamine B; Ab¼ antibody.
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liposome system is used to label the biotin.
Another advantage is the multiplexed nature of a micro-
array assay. STIs involve not only the conventionally named
female reproductive organs, but also the anus or oral cavity;
therefore, there are plenty of microorganisms and pathogens
found, including different kinds of bacteria and viruses from
the cervix. In this situation, it is reasonable and convenient to
use a single approach with a multiplexed nature to detect all
the common microorganisms in one test either by culture35 or
targeting of nucleic acid.36 For an inflammatory disease
caused by various and multiple pathogens, detection of them
all in one multiplexed tool is the best policy. Moreover,
a thorough and detailed therapeutic plan can be useful in
eradicating the infection.35,36
Besides the benefits of high throughput and being multi-
plexed, the amount of sample in this immunoassay can be
lowered to tens of microliters.30 These advantages make the
method more convenient and easier to sue. The best part is that
the estimated cost for each chip is US$3, if 200 chips are
fabricated at the same time. Now, this technique is also being
tested in our laboratory for the detection of gonorrhea infec-
tion. We hope to report the results in the near future.
In conclusion, a brief summary of available methods for the
diagnosis of N. gonorrhoeae infection is listed in Table 1.
Although the traditional methods have higher scores, the
sensitivity of these tools is too low and is not acceptable for
a screening method. In contrast, the NAATs show the best
sensitivity and specificity; however, the application of NAATs
to the clinical practice might not be cost-effective since theTable 1
Comparison and ranking scores of diagnostic tests for gonorrhea infection in wom
Tools Sensitivitya Specificityb Costc Ti
Syndromic 12e83 (1) 43e73 (1) 5 5
Gram’s stain 30e50 (1) 99e100 (5) 4 4
Culture 56 (2) 95 (5) 3 1
Immunoassay 60e85 (2) 90e97 (4) 2 4
NAATs 91e100 (5) 98e100 (5) 1 2
ahighest score, highest sensitivity, bhighest score, highest specificity, chighest scor
score, best facilities, g,hbonus items with an extra score of 1, itotal scores for the oth
of staff; FAC¼ laboratory facilities; SPE¼ spectrum examination; SUS¼ susceptiscore, as shown in Table 1 is not high. This main defect limits
their popularity, and they are not widely used in point-of-care
settings. When considering a screening tool in a developing
country, the tools reviewed above do not fit the routine clinical
practice, which means that we are not still satisfied with these
methods. To achieve the goals of accurate diagnosis and
effective treatment of infectious diseases, such as gonococcal
infection, advances in techniques to aid the detection of
pathogens should be encouraged and supported.24
Factors determining the choice of screening tests for
gonorrhea infection in women might include test sensitivity,
specificity, available antibiotic susceptibility tests, ease of
specimen collection, time, cost, degree of technique difficulty,
and laboratory facilities.21 NAATs supplemented with micros-
copy and culture remain the best choice in an ideal setting of
a developed country.24,29 However, in settings where laboratory
facilities are not fully available, especially in a developing
country or in high-risk populations where return rates are low,
rapid tests using immunoassay may be the most effective way of
diagnosing gonorrhea infection.11,18 The optimal use in these
settings requires the development of rapid tests that are simpler
and cheaper.7 An easy, fast, inexpensive, high-throughput, and
nano-scale-sensitive multiplexed detection system might be
the answer. A clinician might be able to detect the different
pathogens causing cervical and vaginal infections, including
gonorrhoea or chlamydiasis,37 immediately and accurately
using a microarray-based immunoassay. With a sensitive test for
the point-of-care setting, a correct prescription of antibiotics
will be made rapidly and confidently and over- or under-
treatment can be avoided.en
med TRAe FACf SPEg SUSh POCi
5 5 0 0 22
4 4 0 0 22
3 3 0 1 20
2 2 0 0 16
1 1 1 0 16
e, cheapest, dlowest score, shortest time, elowest score, best training, flowest
er items, higher ones might be better for developing countries, TRA¼ training
bility test; POC¼ point of care setting.
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